G - Genpact Limited Stock Analysis | Stock Taper
Logo
Genpact Limited

G

Genpact Limited NYSE
$39.72 0.48% (+0.19)

Market Cap $6.85 B
52w High $54.00
52w Low $34.79
Dividend Yield 1.49%
Frequency Quarterly
P/E 12.69
Volume 2.15M
Outstanding Shares 172.41M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $1.32B $284.5M $143.09M 10.85% $0.83 $200.72M
Q3-2025 $1.29B $278.01M $145.83M 11.29% $0.84 $229.41M
Q2-2025 $1.25B $270.67M $132.72M 10.58% $0.76 $216.27M
Q1-2025 $1.21B $245.29M $130.85M 10.77% $0.75 $214.14M
Q4-2024 $1.25B $255.6M $141.91M 11.36% $0.8 $227.61M

What's going well?

Revenue and gross profit both increased slightly, and operating margins improved a bit. Interest expenses dropped, showing better debt management. The company remains solidly profitable.

What's concerning?

Net income and earnings per share slipped a little, and there is no sign of accelerating growth. Lack of detail on R&D or marketing spend makes it hard to judge future growth potential.

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $1.2B $5.84B $3.29B $2.55B
Q3-2025 $740.76M $5.36B $2.82B $2.54B
Q2-2025 $663.26M $5.31B $2.72B $2.59B
Q1-2025 $561.62M $4.89B $2.44B $2.45B
Q4-2024 $671.61M $4.99B $2.6B $2.39B

What's financially strong about this company?

The company has plenty of cash and investments, a healthy equity cushion, and can easily pay its bills. Liquidity improved this quarter, and there’s no sign of urgent funding needs.

What are the financial risks or weaknesses?

Debt increased sharply, and a large chunk of assets is goodwill from acquisitions, which could be risky if those deals disappoint. Deferred revenue fell to zero, which may signal fewer prepaid contracts.

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2025 $143.09M $286.69M $-371.86M $208.81M $113.07M $269.04M
Q3-2025 $145.83M $308.36M $-19.22M $-208.96M $77.5M $292.02M
Q2-2025 $132.72M $177.37M $-105.2M $18.87M $101.64M $152.76M
Q1-2025 $130.85M $40.44M $779K $-125.54M $-86.63M $17.86M
Q4-2024 $141.91M $203.25M $-41.25M $-517.43M $-374.4M $182.85M

What's strong about this company's cash flow?

The company consistently generates more cash than it reports in profits, with $287 million in operating cash flow and $269 million in free cash flow. The cash balance is rising, and shareholder returns are well covered.

What are the cash flow concerns?

Operating and free cash flow both dipped this quarter, and the company took on $336 million in new debt after paying down debt last quarter. Working capital benefits may not last.

Revenue by Products

Product Q1-2025Q2-2025Q3-2025Q4-2025
Consumer And Healthcare
Consumer And Healthcare
$420.00M $430.00M $430.00M $450.00M

Revenue by Geography

Region Q1-2019Q2-2019Q3-2019Q4-2019
Americas
Americas
$180.00M $210.00M $230.00M $240.00M
Asia Other Than India
Asia Other Than India
$90.00M $80.00M $90.00M $100.00M
Europe
Europe
$100.00M $110.00M $100.00M $110.00M
INDIA
INDIA
$440.00M $490.00M $470.00M $490.00M

Q4 2025 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at Genpact Limited's financial evolution and strategic trajectory over the past five years.

+ Strengths

Genpact combines steady revenue growth, improving margins, and strong cash generation with a healthier, less leveraged balance sheet. Strategically, it benefits from deep process and industry expertise, a long-standing operational excellence culture, and a rapidly expanding AI and digital solutions portfolio supported by major cloud partnerships. These factors together create a business that is financially resilient and competitively differentiated within its chosen niches.

! Risks

Key risks include rising overhead costs, the accounting opacity around R&D spending, and significant goodwill and intangible assets that depend on ongoing acquisition success. The company also operates in an intensely competitive and fast-changing technology landscape, where missteps in AI execution, pricing pressure, client insourcing, or sector-specific downturns could weigh on growth and margins. Shifts in capital allocation—such as pausing debt reduction or buybacks—add another layer of uncertainty around how future cash flows will be used.

Outlook

The overall picture points to a company on an improving financial trajectory, using its balance sheet strength and cash flow to fund a strategic pivot toward AI-led, higher-value services. If Genpact can sustain its innovation pace, manage costs, and deepen its role in clients’ mission-critical operations, it is positioned for continued, though not risk-free, growth in both scale and profitability. Execution on its AI roadmap and disciplined capital allocation will be the main drivers of how favorable that future ultimately looks.